Topical pharmaceutical formulations and methods of treatment
First Claim
1. A pharmaceutical formulation for dermal administration to a mammal, the formulation being a solid, unit dosage form and comprising a unit dose of a therapeutically effective amount of at least 1% by weight of one or more therapeutic agents and a pharmaceutically acceptable carrier medium,said formulation being solid at ambient temperature and having a softening point from 30°
- C. to not higher than 35°
C., such that upon being placed in continuous contact with an area of the skin of a mammalian patient to be treated, it is softened or melted to effect administration of the unit dose of said therapeutic agent to the mammalian patient within a time period of less than 5 minutes,wherein said formulation is in the form of a tablet and has at least one surface which is flat, andwherein the carrier medium comprises cocoa butter or one or more glycerides, where the glycerides are selected from the group consisting of mono-glycerides, di-glycerides and tri-glycerides andthe formulation is not provided as a medicinal transdermal patch or plaster.
2 Assignments
0 Petitions
Accused Products
Abstract
In certain embodiments, the present invention is directed to a pharmaceutical formulation for topical administration on a mammal, comprising a unit dose of a therapeutically effective amount of a therapeutic agent and a pharmaceutically acceptable carrier medium therefor, said formulation being solid at ambient temperature and having a softening point of not higher than 35° C., such that when the formulation is placed in continuous contact with the skin of a mammalian patient, it is softened to a consistency to effect substantial application of the unit dose of said therapeutic agent onto a desired skin area of the mammalian patient within a time period of less than 10 minutes.
-
Citations
46 Claims
-
1. A pharmaceutical formulation for dermal administration to a mammal, the formulation being a solid, unit dosage form and comprising a unit dose of a therapeutically effective amount of at least 1% by weight of one or more therapeutic agents and a pharmaceutically acceptable carrier medium,
said formulation being solid at ambient temperature and having a softening point from 30° - C. to not higher than 35°
C., such that upon being placed in continuous contact with an area of the skin of a mammalian patient to be treated, it is softened or melted to effect administration of the unit dose of said therapeutic agent to the mammalian patient within a time period of less than 5 minutes,wherein said formulation is in the form of a tablet and has at least one surface which is flat, and wherein the carrier medium comprises cocoa butter or one or more glycerides, where the glycerides are selected from the group consisting of mono-glycerides, di-glycerides and tri-glycerides and the formulation is not provided as a medicinal transdermal patch or plaster. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)
- C. to not higher than 35°
Specification